Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bristol-Myers Gets SEC Subpoena In Foreign Bribery Probe

04/26/2012 | 01:01pm US/Eastern
   By Peter Loftus 
   Of  
 

Drug maker Bristol-Myers Squibb Co. (>> Bristol Myers Squibb Co.) said it has received a subpoena from the U.S. Securities and Exchange Commission as part of an investigation into bribery overseas.

Bristol-Myers said the subpoena received in March seeks information related to sales and marketing practices in "various countries."

The New York-based company said in a quarterly report filed Thursday with the SEC that it was cooperating with the government. A spokeswoman declined comment beyond the information in Thursday's SEC filing.

Bristol-Myers, which sells the anti-clotting drug Plavix, previously disclosed that the SEC was investigating the activities of the company's units in Germany, concerning potential violations of the U.S. Foreign Corrupt Practices Act, or FCPA.

U.S. authorities in recent years have stepped up enforcement of the FCPA, which bars U.S. companies from bribing foreign officials to obtain or retain business. Multinational drug and medical-device makers based in the U.S. have been among the targets of enforcement.

Last year, Johnson & Johnson (>> Johnson & Johnson) agreed to pay nearly $80 million to resolve allegations that it paid bribes to doctors in three European countries, as well as kickbacks to Iraq to illegally obtain business under former leader Saddam Hussein.

Other drug makers--including Pfizer Inc. (>> Pfizer Inc.), Merck & Co. (>> Merck & Co., Inc.) and Eli Lilly & Co. (>> Eli Lilly & Co.)--also have been the subjects of federal inquiries regarding the FCPA.

-By Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

React to this article
Latest news on BRISTOL-MYERS SQUIBB CO
08:36aDJBRISTOL MYERS SQUIBB : -Myers Myeloma Drug Accepted for FDA Review
08:25aDJBRISTOL MYERS SQUIBB : -Myers Myeloma Drug Accepted for Priority Review
06:35a BRISTOL MYERS SQUIBB : Enters into Option to Acquire Promedior and PRM-151 for u..
08/31DJBRISTOL MYERS SQUIBB : -Myers Granted Right to Buy Promedior
08/31 BRISTOL MYERS SQUIBB : -Myers buys rights to fibrosis drug
08/31DJBRISTOL MYERS SQUIBB : -Myers Granted Right to Buy Promedior for up to $1.25 Bil..
08/31 BRISTOL MYERS SQUIBB : Enters Agreement Providing Exclusive Right to Acquire Pro..
08/31DJStocks End August With Another Loss
08/31 BRISTOL MYERS SQUIBB : Allied-Bristol Life Sciences Licenses Platform Technology..
08/31 BRISTOL MYERS SQUIBB : Allied Minds Reports Half-Yearly Results
Advertisement
Chart
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Income Statement Evolution
More Financials